Abstract
Purpose To assess the impact of maintenance therapy and the additional impact of dexamethasone treatment on cancer-related fatigue and sleep-wake rhythms in pediatric acute lymphoblastic leukemia (ALL) patients and to determine the association between these outcomes. Methods A national cohort of pediatric ALL patients (>= 2 years) was included (+/- 1 year post-diagnosis). Patients receiving dexamethasone were assessed twice (assessment with and without dexamethasone). Actigraphy assessments were used to calculate sleep-wake outcomes with nonparametric methods. Cancer-related fatigue was assessed with the PedsQL Multidimensional Fatigue Scale. Sleep-wake rhythms and cancer-related fatigue were compared between patients participating in the assessment without dexamethasone and healthy children (linear regression) and between assessments with and without dexamethasone (mixed models). Using linear regression, associations between sleep-wake outcomes and cancer-related fatigue were determined during assessments with and without dexamethasone. Results Responses were collected for 125 patients (113 assessments with and 81 without dexamethasone). The sleep-wake rhythm was less stable (p = 0.03) and less robust (p = 0.01), with lower physical activity levels (p <0.001) and higher cancer-related fatigue levels (p <0.001) in ALL patients compared to healthy children. Physical activity was lower (p = 0.001) and cancer-related fatigue more severe (p
Original language | English |
---|---|
Pages (from-to) | 5983-5993 |
Number of pages | 11 |
Journal | Supportive Care in Cancer |
Volume | 28 |
Issue number | 12 |
DOIs | |
Publication status | Published - 13-Apr-2020 |
Keywords
- Sleep
- Cancer-related fatigue
- Acute lymphoblastic leukemia
- Pediatric
- Actigraphy
- Dexamethasone
- QUALITY-OF-LIFE
- CHILD SLEEP
- DEXAMETHASONE
- ACTIGRAPHY
- PATTERNS
- ADOLESCENTS
- RELIABILITY
- PREDNISONE
- PEDSQL(TM)
- VALIDITY